bpc-157 demyelination The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Stable gastric pentadecapeptide BPC 157

no adverse event accumulation

Contraindications Acute critical illness due to heart, multiple accidental trauma or respiratory failure

L., Mingels C., et al

Its an excellent supplement for those looking to enhance their weight loss efforts, improve energy, and support liver health

Oral Protocol (Gut Health Focus) Loading Phase (Weeks 1 to 4): BPC-157: 250 to 500 mcg per day, oral capsule or solution, taken on an empty stomach KPV: 500 to 1,000 mcg per day, oral capsule or solution, taken with or without food Maintenance Phase (Weeks 5 to 8): BPC-157: 250 mcg per day KPV: 500 mcg per day Cycle Length: 8 weeks total, followed by a 4-week break

Nature 2004, 427, 360364